Knjižnica dokumenata

Analize i izvješća iz think-tankova i OSINT izvora

An explosive novel probes the roots of homophobia in Senegal, where a chilling anti-LGBTQ+ law just passed.

Test yourself on the week of July 25: India’s Cockroach movement gets a win, Burnham receives his first foreign leader, and Peru inaugurates a new president.

As Western aid retreats and Chinese investment shifts, the continent needs a model that is truly its own.

Washington is losing influence to Beijing in a strategic region.

The Trump administration has shared few details and little evidence.

What a recent scandal reveals about the country’s political culture.

Violence is escalating, but it also follows familiar trends.

Secretary-General Mark Rutte warned that Moscow’s “reckless” actions risk spreading the Ukraine war.

India’s prime minister is famous for his savvy use of social media. Now he’s getting a wake-up call.

The late senator’s long-stalled Russia sanctions bill is on its way to becoming law.

Iraq’s new prime minister faces a familiar challenge in confronting Iran-backed groups.

Daniel Yergin on China’s surprising role as a shock absorber.

The administration’s inconsistency has undermined a key tool of U.S. foreign policy.

Attempts at control are futile. Policy should now turn to defense.

The Iran war has underscored the need for a change in state psychology.

Amid extreme heat, demonstrators are protesting power cuts—and the governments behind them.

Iraqi militias backed by Tehran are the latest targets in the ever-expanding conflict.

Trump needs to learn the diplomatic art of losing well.

India’s youth-led protest movement led to a rare instance of the government giving in.

Building an independent defense industry does not mean going it alone.

How to build a world order with leaders who prefer Trump to Carney.

After oil refineries and cargo ships, Ukraine is now taking out Russian e-commerce.

The South China Sea ran a distant second.

The coming months will mark the most dangerous phase of Russia’s war in Ukraine.

The death of a child during an experimental gene-editing trial renews questions about biotech ethics and ambitions.